THERAPEUTIC APHERESIS AND DIALYSIS

Scope & Guideline

Exploring cutting-edge methodologies in apheresis and dialysis.

Introduction

Delve into the academic richness of THERAPEUTIC APHERESIS AND DIALYSIS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1744-9979
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2003 to 2024
AbbreviationTHER APHER DIAL / Ther. Apher. Dial.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "Therapeutic Apheresis and Dialysis" focuses on advancing the knowledge and practice of therapeutic apheresis and dialysis, encompassing a wide range of conditions and treatment modalities. Its scope includes clinical applications, innovative therapies, and research findings that contribute to the understanding of renal replacement therapies and their impact on patient outcomes.
  1. Therapeutic Apheresis:
    The journal emphasizes the role of therapeutic apheresis in treating various medical conditions, including autoimmune disorders, hematological diseases, and complications arising from chronic kidney disease. It includes studies on the efficacy and safety of procedures such as plasma exchange and leukapheresis.
  2. Dialysis Modalities:
    Research on different dialysis modalities, including hemodialysis and peritoneal dialysis, is a core focus. The journal covers topics related to the optimization of dialysis techniques, patient management, and long-term outcomes of dialysis therapies.
  3. Innovative Treatment Approaches:
    The journal highlights innovative treatment approaches, such as the use of machine learning in predicting patient outcomes, novel dialysis membranes, and blood purification technologies. This includes advancements in therapeutic devices and their clinical applications.
  4. Patient-Centered Care:
    Studies focusing on patient-centered care, quality of life, and psychosocial aspects of treatment in patients undergoing dialysis and apheresis are integral. This includes research on patient education, adherence to treatment, and shared decision-making.
  5. Epidemiology and Outcomes:
    The journal publishes epidemiological studies that assess patient populations undergoing dialysis and apheresis, detailing outcomes related to mortality, morbidity, and complications associated with these therapies.
The journal has shown a dynamic evolution in its research focus, with certain themes emerging as significant areas of interest. These trends reflect current healthcare challenges, technological advancements, and the increasing importance of personalized medicine.
  1. Machine Learning and Predictive Analytics:
    There is a growing trend towards utilizing machine learning and predictive analytics in the management of dialysis and apheresis patients. This includes developing models to predict outcomes such as mortality and treatment response, indicating a shift towards data-driven decision-making.
  2. Patient Quality of Life and Psychosocial Factors:
    Recent publications have increasingly focused on the quality of life, mental health, and psychosocial factors affecting patients undergoing dialysis and apheresis. This trend highlights the importance of holistic care in managing chronic kidney disease.
  3. Advanced Dialysis Technologies:
    Emerging technologies, such as medium-cut-off dialyzers and innovative blood purification methods, are gaining traction in the literature. Research into these advanced modalities aims to improve patient outcomes and reduce complications.
  4. COVID-19 Impact Studies:
    The ongoing impact of COVID-19 on patients undergoing dialysis and apheresis has led to a surge in related research. Studies addressing infection rates, vaccine responses, and management strategies during the pandemic have become increasingly relevant.
  5. Nutritional Interventions:
    An increasing number of studies are focusing on nutritional interventions and their effects on patients undergoing dialysis. This emerging theme explores the links between nutrition, inflammation, and overall health outcomes in this population.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have seen a decline in focus over recent years. These waning scopes may reflect shifting priorities in research or advancements that have reduced the need for investigation in those areas.
  1. Basic Science Research:
    There has been a noticeable decline in basic science research related to the mechanisms of apheresis and dialysis. As clinical applications and outcomes take precedence, foundational studies seem to be less frequently published.
  2. Traditional Dialysis Techniques:
    Research focusing solely on traditional dialysis techniques without innovation or comparative analysis appears to be waning. As newer technologies and methodologies are developed, studies on conventional approaches are becoming less prominent.
  3. Apheresis in Non-Renal Diseases:
    The exploration of apheresis applications in non-renal diseases has decreased. While apheresis remains relevant for renal conditions, its use in broader medical contexts appears less frequently discussed in recent publications.
  4. Longitudinal Studies:
    Longitudinal studies that track outcomes over extended periods have become less common. This may reflect a shift towards more immediate, short-term studies that provide quicker results and insights.
  5. Economic Evaluations:
    Research focusing on the economic aspects of apheresis and dialysis, including cost-effectiveness analyses, seems to be less represented. As funding and resources shift, this area may be receiving less attention.

Similar Journals

Clinical and Experimental Nephrology

Advancing kidney health through rigorous research.
Publisher: SPRINGERISSN: 1342-1751Frequency: 6 issues/year

Clinical and Experimental Nephrology, published by SPRINGER, serves as a crucial platform for researchers and practitioners in the field of nephrology. With its roots dating back to 1999, the journal has made significant strides in exploring various dimensions of kidney health, thereby enriching our understanding of nephrological diseases. Aimed at fostering interdisciplinary dialogue, it covers a broad spectrum of topics from clinical practices to experimental research, evidenced by its ranked quartiles of Q2 in Nephrology and Q3 in both Physiology and Medical Physiology within its latest evaluation. Although not open access, the journal's rigorous peer-review process ensures the publication of high-quality research, making it a valuable resource for professionals, academic institutions, and students. The journal is located in Japan, with its editorial office situated at One New York Plaza, Suite 4600, New York, NY 10004, United States, reflecting its global influence and intent to disseminate critical findings in nephrology and beyond.

Canadian Journal of Kidney Health and Disease

Elevating kidney health research to new heights.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS

Transforming Lives Through Cutting-Edge Research.
Publisher: SAGE PUBLICATIONS LTDISSN: 0391-3988Frequency: 12 issues/year

International Journal of Artificial Organs is a prestigious peer-reviewed journal published by SAGE Publications Ltd, dedicated to advancing the field of bioengineering, biomaterials, and biomedical engineering. Established in 1978, the journal has a rich history of contributing to the research community with cutting-edge studies and advancements in artificial organ technology and related disciplines. With an impact factor that positions it in the Q3 category across multiple fields, including Medicine and Engineering, the journal serves as a vital resource for researchers, professionals, and students interested in innovative solutions for organ replacement and support. While it is not an open-access journal, it offers subscription-based access, ensuring the dissemination of high-quality research to stakeholders globally. Located in Italy, the journal’s scope encompasses a variety of disciplines, making it essential reading for those at the forefront of medical technology development. Explore the latest breakthroughs and join a community committed to transforming lives through science and engineering.

Nephrologie & Therapeutique

Exploring the forefront of nephrological innovation.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1769-7255Frequency: 7 issues/year

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

NEPHROLOGY DIALYSIS TRANSPLANTATION

Elevating the standards of kidney care through research.
Publisher: OXFORD UNIV PRESSISSN: 0931-0509Frequency: 12 issues/year

NEPHROLOGY DIALYSIS TRANSPLANTATION is a premier academic journal published by Oxford University Press that plays a vital role in disseminating cutting-edge research within the fields of nephrology and transplantation. With an impressive impact factor and recognition as Q1 in both these categories for 2023, the journal ranks among the top publications in medicine, enhancing its visibility among a global audience of researchers, healthcare professionals, and students. Established in 1986, the journal has maintained a commitment to publishing high-quality, peer-reviewed articles that contribute to the advancement of knowledge and practice in renal medicine. Although this journal does not offer open access options, it remains a highly regarded resource due to its rigorous selection process and influential contributions to the field. Scholars are encouraged to explore the journal’s extensive archive, spanning from 1986 to 2024, for invaluable insights and developments in nephrology and transplantation.

Lancet Haematology

Advancing hematology through innovative research.
Publisher: ELSEVIER SCI LTDISSN: 2352-3026Frequency: 12 issues/year

Lancet Haematology, published by Elsevier Science Ltd in the United Kingdom, is a premier peer-reviewed journal dedicated to advancing the field of hematology. With an impressive impact factor and listed in the Q1 category in hematology for 2023, this journal ranks #4 out of 137 in the Scopus database, boasting a 97th percentile indicating its influential role in disseminating high-quality research. Since its establishment in 2014, Lancet Haematology has provided a vital platform for researchers and clinicians to share groundbreaking studies, innovative treatment approaches, and novel therapeutic discoveries relevant to various hematological disorders. The journal does not operate under an open access model, but it offers multiple access options to facilitate engagement with its content. By bridging clinical practice and cutting-edge research, Lancet Haematology aims to foster the advancement of knowledge and improve patient outcomes in hematology, making it an essential read for professionals, researchers, and students alike.

Case Reports in Nephrology and Dialysis

Transforming nephrology with every case report.
Publisher: KARGERISSN: 2296-9705Frequency: 3 issues/year

Case Reports in Nephrology and Dialysis, published by KARGER, is a vital peer-reviewed journal dedicated to the dissemination of case reports and innovative findings in the fields of nephrology and dialysis. Since its inception in 2015, this Open Access journal has aimed to foster knowledge exchange and improve patient outcomes through comprehensive case studies, clinical insights, and recent advancements in renal healthcare. Based in Switzerland, the journal is poised to serve a global audience, accommodating research that spans diverse geographical and clinical contexts. Currently ranked in the Q3 category for nephrology in 2023, it underscores its burgeoning influence in the medical literature, despite its relatively nascent presence. As a valuable resource for researchers, healthcare professionals, and students, it provides a platform for sharing unique cases that enrich the understanding of complex renal issues and challenges faced in dialysis. With an emphasis on high-quality, accessible research, Case Reports in Nephrology and Dialysis is committed to advancing nephrology and dialysis practices through collaboration and knowledge sharing.

AMERICAN JOURNAL OF NEPHROLOGY

Pioneering insights in kidney disease management.
Publisher: KARGERISSN: 0250-8095Frequency: 12 issues/year

The American Journal of Nephrology, published by KARGER, stands as a prestigious platform for the dissemination of high-quality research in the field of nephrology, boasting an impressive Q1 ranking in its category as of 2023. With its ISSN 0250-8095 and E-ISSN 1421-9670, the journal has been committed to advancing knowledge in kidney diseases since its inception in 1981. It serves as an essential resource for researchers, clinicians, and students alike, featuring original articles, reviews, and case reports that contribute to the understanding and treatment of renal conditions. Despite not being an open-access journal, the American Journal of Nephrology ensures a rigorous peer-review process to maintain its high academic standards, making it a vital source of information for the nephrology community worldwide. By providing insights into emerging trends and breakthroughs in kidney health, the journal continues to play a crucial role in shaping the future of nephrology research.

Hemodialysis International

Pioneering Insights for Better Renal Care
Publisher: WILEYISSN: 1492-7535Frequency: 4 issues/year

Hemodialysis International is a prominent academic journal dedicated to advancing the field of nephrology and hematology, published by WILEY. With its ISSN 1492-7535 and E-ISSN 1542-4758, this journal serves as a crucial platform for researchers and clinicians to disseminate impactful findings related to hemodialysis and renal care. As it approaches its twentieth year of publication from 2004 to 2024, Hemodialysis International has established itself within the Q3 quartile rankings in both Hematology and Nephrology, reflecting its commitment to scholarly excellence and relevance in the field. Though it is not an open-access journal, it offers various subscription options, making its valuable insights accessible to a broad audience. Researchers, healthcare professionals, and students are encouraged to engage with the journal’s contributions, which encompass innovative research, clinical studies, and reviews, all aimed at improving patient care and outcomes in hemodialysis.

Journal of Renal Care

Empowering nephrology with cutting-edge insights.
Publisher: WILEYISSN: 1755-6678Frequency: 4 issues/year

The Journal of Renal Care, published by Wiley, stands as a leading scholarly platform for researchers, healthcare professionals, and students dedicated to advancements in nephrology and specialized nursing practices. With an impact factor that reflects its high degree of influence in the field—ranking in the Q1 category for Advanced and Specialized Nursing and Q2 for Nephrology based on 2023 metrics—it serves as an essential resource for innovative research and clinical insights. The journal's ISSN (1755-6678) and E-ISSN (1755-6686) facilitate easy access to cutting-edge studies and reviews that have shaped the scope of renal care since its inception in 2006, with a converged publication span extending until 2024. Addressing the pressing challenges within nephrology, this journal fosters a stimulating academic environment, enhancing the quality of patient care through rigorous peer-reviewed research and dialogue. As it continues to contribute significantly to both nursing and medical disciplines, the Journal of Renal Care remains a pivotal source for nurturing knowledge and advancing practice in renal healthcare.